These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Biochemical basis for using selective monoamine oxidase inhibitors in the treatment of Parkinson's disease. Critical contribution]. Amato L, Nava L, Rizzo M, Piccoli F. Riv Neurol; 1985; 55(1):46-52. PubMed ID: 3927468 [No Abstract] [Full Text] [Related]
18. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group. Larsen JP, Boas J. Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975 [Abstract] [Full Text] [Related]
19. L-deprenyl in the treatment of Parkinson's disease. Csanda E, Tárczy M, Takáts A, Mogyorós I, Köves A, Katona G. J Neural Transm Suppl; 1983 Mar; 19():283-90. PubMed ID: 6421993 [Abstract] [Full Text] [Related]